Quoin pharmaceuticals: strategically building for future success

As the rare disease drug development landscape continues to evolve, quoin (nasdaq: qnrx) is focused on staying ahead of its competitors.new york, new york--(newsfile corp. - june 14, 2022) - pcg digital -- the life sciences industry has always been dynamic; a collective of organizations from small and agile to large multinationals with one common feature, a need to be creative enough to adapt and change course as challenges arise. social, political and economic influences, the regulatory environment and competition from deep-pocketed big pharma all present substantial challenges for small biotech companies. the overarching question...
QNRX Ratings Summary
QNRX Quant Ranking